Other News

Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system

HANGZHOU, China, March 18, 2022 /PRNewswire/ — On March 18th, 2022, Venus Medtech (Hangzhou) Inc. (“Venus Medtech”, 2500.HK), a leading provider of integrated solutions for structural heart disease in China, announced the appointment of Shakeel Osman as Senior Vice President of Sales Europe, responsible for the commercialization of congenital heart devices. At present, the company’s transcatheter […]

Tampa General Hospital and USF Health are First in Florida and Second in the U.S. to Replace a Tricuspid Valve… (cont’d)

Tampa General Hospital and USF Health are First in Florida and Second in the U.S. to Replace a Tricuspid Valve in the Heart Through a Minimally Invasive Procedure Using Transcatheter Bicaval Implants (TricValve) TAMPA, Fla., March 18, 2022 /PRNewswire/ — Tampa General Hospital (TGH) and USF Health Morsani College of Medicine Interventional Cardiologists reached multiple milestones […]

Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin

THE WOODLANDS, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it entered into a loan facility with Oxford Finance LLC that provides up to $150 million in borrowing capacity designed primarily to support commercial preparations and the potential launch of sotagliflozin in heart failure. “This loan […]

Transparency Notifications from Shareholders

GHENT, Belgium, March 18, 2022 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting […]

Medtronic appoints new Operating Unit Presidents

Que Dallara joins as EVP & President, Diabetes Mike Marinaro named President, Surgical Robotics Dr. Kweli Thompson named President, Cardiac Rhythm Management DUBLIN, March 17, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – […]

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Study” in the prestigious American Journal of Respiratory and Critical Care Medicine – which has an impact factor of 21.4. The article […]

Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update

– Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder – Expanded use of Treprostinil Injection to include subcutaneous administration – Preparing to launch YUTREPIA in late-2022 pending final FDA approval – Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., March 17, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation […]

CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes

BOSTON, March 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today announced that the Company will be added to the Russell 2000® and Russell 3000® Indexes, effective on Friday, […]